Surgery Websites
Department of Surgery »  Faculty »  Surgical Oncology »  Carlos U. Corvera, M.D.

Carlos U. Corvera, M.D., FACS

  • Professor & Chief, Section of HPB-GISS (HepatoPancreatoBiliary, GI, Skin, Sarcoma Surgery)
  • Maurice Galante Distinguished Professorship in Hepatobiliary Surgery

Contact Information

Academic Office
1600 Divisadero Street
Box 1932 | University of California, San Francisco
San Francisco, CA 94143-1932
Voice (415) 353-9294
Fax (415) 353-9695
Carlos.Corvera@ucsf.edu
Open Popup

1983-86 University of California, Davis, CA  B.S. Biochemistry College of Agricultural and Environmental Science
1989-93 University of California, San Diego Medical School.  M.D.  La Jolla, CA

  • 1993-1995,University of California, San Francisco, Intern and Resident,Surgery
  • 1995-1998 University of California, San Francisco, Research Fellow Surgery, Division of Gastrointestinal Surgery
  • 998-2000,University of California, San Francisco, Senior Resident Surgery
  • 2000-2001,University of California, San Francisco, Chief Resident Surgery
  • 2001-2002, Memorial Sloan-Kettering Cancer Center, Fellow ,Surgical Oncology, New York,  New York
  • 2002-2003, Memorial Sloan-Kettering Cancer Center, Fellow, Hepatobiliary Surgery, New York,  New York
  • American Board of Surgery
  • Hepatobiliary and Pancreas Surgery Program
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Department of Surgery at the San Francisco VA
  • Proteases and Proteinase Activated Receptors in the Biliary Tract

Carlos Corvera, M.D. is Professor of Surgery and Chief of Hepatobiliary and Pancreas Surgery at UCSF.  A trained surgical oncologist, Dr. Corvera has extensive experience in the treatment of benign and malignant hepatobiliary disease including hepatocellular carcinoma (primary liver cancer), liver metastases, and cancers of the stomach, gall bladder, bile ducts, and pancreas. Additionally, Dr. Corvera performs surgery for  melanoma and  soft tissue sarcomas. Dr. Corvera specializes in complex and intricate cancer surgeries, including minimally invasive liver resections that greatly minimize post-operative pain and speed recovery. Dr. Corvera, who performs a high volume of such procedures, is also a pioneer and innovator of surgical techniques in the field.

Dr. Corvera graduated from the University of California San Diego School of Medicine. He completed his general surgery residency at UCSF, and prestigious fellowships in surgical oncology and hepatobiliary surgery at Memorial Sloan-Kettering Cancer Center. 

In May 2013, Dr. Corvera was installed as the President of the UCSF Naffziger Surgical Society, the alumni society for the UCSF Department of Surgery and served for the 2013-2014 term. Dedicated to surgical excellence, the society has long served as a forum fostering collaboration between surgeons and promoting surgical advances through its educational forums.

Dr. Corvera's scientific research interest is focused on understanding the mechanisms of biliary tract fibrosis and inflammation.  More specifically, he is interested in studying the clinical consequences of biliary fibrosis-- mainly cholestatisis. Cholestasis is characterized by impaired bile flow causing a high concentration of bile acids in the liver and the circulation.  Prolonged exposure to bile acids in the liver can progress to end-stage liver disease and cirrhosis. In the gastrointestinal tract, the absence of bile flow causes profound local and systemic metabolic disturbances. Dr.Corvera is actively investigating the role of a novel cell surface receptor specific for bile acids that may play a critical role in normal and disease states.

MOST RECENT PUBLICATIONS FROM A TOTAL OF 64
Data provided by UCSF Profiles, powered by CTSI
  1. Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA. ASO Visual Abstract: Determining Hospital Volume Threshold for the Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis. Ann Surg Oncol. 2022 Jan 15. View in PubMed
  2. Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA. Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis. Ann Surg Oncol. 2022 Mar; 29(3):1566-1574. View in PubMed
  3. Mosenia A, Ward C, Yee A, Qorbani A, Corvera C. Multifocal pancreatic PPoma in the setting of MEN1: Case report and review of literature. Int J Surg Case Rep. 2021 Jun; 83:106008. View in PubMed
  4. Thiruvengadam NR, Miranda J, Kim C, Behr S, Corvera C, Dai SC, Kirkwood K, Harris HW, Hirose K, Nakakura E, Ostroff JW, Kochman ML, Arain MA. Burden of Ionizing Radiation in the Diagnosis and Management of Necrotizing Pancreatitis. Clin Transl Gastroenterol. 2021 04 27; 12(5):e00347. View in PubMed
  5. Mahuron KM, Kasai Y, Javeed ZA, Bergsland EK, Hirose K, Corvera CU, Nakakura EK. Minimally Invasive Surgery for Ileal Neuroendocrine Tumors. J Gastrointest Surg. 2021 11; 25(11):2954-2956. View in PubMed
  6. View All Publications

 

Site Directory
    X